- POCT
- Test Item
SGTi-flexM COVID-19 & Flu A/B Ag
COVID-19 & Influenza A/B Rapid Antigen Simultaneous Test
Overview
SGTi-flexM COVID-19 & Flu A/B Ag is an in vitro diagnostic medical device that qualitatively detects SARS-CoV-2, influenza A, and influenza B antigens in nasopharyngeal samples from individuals suspected of COVID-19 or influenza virus infection, using the immunochromatographic method.
It enables easy, accurate, and simultaneous diagnosis of COVID-19 and influenza A/B.
SGTi-flexM differentiates between COVID-19 and influenza A/B results through distinct test line colors—blue for COVID-19 and red for influenza A/B—providing clearer visual interpretation and reducing the risk of result confusion.
Key Features
| Product overview | Simultaneous qualitative analysis (visual inspection) of SARS-CoV-2 and influenza A and B viral antigens • Sensitivity: SRAS-CoV-2 91.00% / Influenza A 92.50% / Influenza B 91.25% • Specificity: SRAS-CoV-2 100% / Influenza A 100% / Influenza B 100% |
|---|---|
| Specimen type | Nasopharyngeal swab |
| Test time | 15 min |
| Storage conditions and expiration date | 2-30℃, 24 months |
| Packaging unit | 25 tests/kit |